Nathan Weinstein
Stock Analyst at Aegis Capital
(0.28)
# 4,380
Out of 5,139 analysts
59
Total ratings
13.79%
Success rate
-24.81%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $0.91 | +8,701.85% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $400 → $300 | $11.15 | +2,590.58% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.21 | +2,826.83% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $0.95 | +3,584.21% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $2.04 | +194.12% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $3.22 | +831.68% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $10.05 | -0.45% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $17.06 | +187.22% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $63,000 → $1,800 | $2.40 | +74,900.00% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $6.12 | +35,194.12% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $1.44 | +8,233.33% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $0.55 | +1,705.05% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $23.90 | +134.31% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $3.56 | +658.43% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $0.80 | +4,288.71% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.44 | +733.33% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $23.41 | +220.38% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $88 | $2.16 | +3,974.07% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.53 | +34,029.69% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $135 | $12.40 | +988.71% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $6.48 | +116.05% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $220 | $15.60 | +1,310.26% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $2.85 | +198.25% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $0.91
Upside: +8,701.85%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $400 → $300
Current: $11.15
Upside: +2,590.58%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.21
Upside: +2,826.83%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $0.95
Upside: +3,584.21%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $2.04
Upside: +194.12%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $3.22
Upside: +831.68%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $10.05
Upside: -0.45%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $17.06
Upside: +187.22%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $63,000 → $1,800
Current: $2.40
Upside: +74,900.00%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $6.12
Upside: +35,194.12%
Dec 7, 2021
Initiates: Buy
Price Target: $120
Current: $1.44
Upside: +8,233.33%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $0.55
Upside: +1,705.05%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $23.90
Upside: +134.31%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $3.56
Upside: +658.43%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $0.80
Upside: +4,288.71%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $1.44
Upside: +733.33%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $23.41
Upside: +220.38%
Oct 19, 2020
Maintains: Buy
Price Target: $104 → $88
Current: $2.16
Upside: +3,974.07%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $0.53
Upside: +34,029.69%
Aug 3, 2020
Maintains: Buy
Price Target: $195 → $135
Current: $12.40
Upside: +988.71%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $6.48
Upside: +116.05%
May 4, 2020
Maintains: Buy
Price Target: $180 → $220
Current: $15.60
Upside: +1,310.26%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $2.85
Upside: +198.25%